Ahn and colleagues have elucidated the anticancer potential of GS against MM cells, demonstrating that GS suppresses STAT3 activation by inducing the expression of protein tyrosine phosphatase (PTP), SH2 domain-containing phosphatase 1 SHP-1 [29]. The gene discussed is STAT3; the disease is Miyoshi myopathy.